OA11959A - Diaminothiazoles and their use for inhibiting protein kinases. - Google Patents

Info

Publication number

OA11959A

OA11959A OA1200100321A OA1200100321A OA11959A OA 11959 A OA11959 A OA 11959A OA 1200100321 A OA1200100321 A OA 1200100321A OA 1200100321 A OA1200100321 A OA 1200100321A OA 11959 A OA11959 A OA 11959A

Authority

OA

OAPI

Prior art keywords

amino

aryl

heteroaryl

formula

substituted

Prior art date

1999-06-04

Links

• Espacenet
• Global Dossier
• Discuss

• 102000001253 Protein Kinase Human genes 0.000 title claims abstract description 30
• 108060006633 protein kinase Proteins 0.000 title claims abstract description 30
• WKXCZMFWXZRMEZ-UHFFFAOYSA-N 1,3-thiazole-2,4-diamine Chemical class NC1=CSC(N)=N1 WKXCZMFWXZRMEZ-UHFFFAOYSA-N 0.000 title abstract description 7
• 230000002401 inhibitory effect Effects 0.000 title description 7
• 150000001875 compounds Chemical class 0.000 claims abstract description 146
• 230000000694 effects Effects 0.000 claims abstract description 44
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 17
• 201000010099 disease Diseases 0.000 claims abstract description 16
• 230000033115 angiogenesis Effects 0.000 claims abstract description 15
• 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 14
• 125000003118 aryl group Chemical group 0.000 claims description 83
• 125000000217 alkyl group Chemical group 0.000 claims description 79
• 125000001072 heteroaryl group Chemical group 0.000 claims description 73
• -1 aiyl Chemical group 0.000 claims description 52
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 44
• 125000000753 cycloalkyl group Chemical group 0.000 claims description 42
• 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 39
• 239000001257 hydrogen Substances 0.000 claims description 37
• 229910052739 hydrogen Inorganic materials 0.000 claims description 37
• 125000003545 alkoxy group Chemical group 0.000 claims description 31
• 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 23
• 239000000651 prodrug Substances 0.000 claims description 23
• 229940002612 prodrug Drugs 0.000 claims description 23
• 229910052799 carbon Inorganic materials 0.000 claims description 21
• 229910052760 oxygen Inorganic materials 0.000 claims description 18
• 125000003342 alkenyl group Chemical group 0.000 claims description 13
• 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 12
• 125000005843 halogen group Chemical group 0.000 claims description 11
• 239000003981 vehicle Substances 0.000 claims description 10
• 229910052757 nitrogen Inorganic materials 0.000 claims description 9
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 8
• 229910052717 sulfur Inorganic materials 0.000 claims description 8
• MPVDXIMFBOLMNW-UHFFFAOYSA-N chembl1615565 Chemical group OC1=CC=C2C=C(S(O)(=O)=O)C=C(S(O)(=O)=O)C2=C1N=NC1=CC=CC=C1 MPVDXIMFBOLMNW-UHFFFAOYSA-N 0.000 claims description 7
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
• 102000005962 receptors Human genes 0.000 claims description 7
• 108020003175 receptors Proteins 0.000 claims description 7
• 125000004093 cyano group Chemical group *C#N 0.000 claims description 6
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 6
• 239000003937 drug carrier Substances 0.000 claims description 5
• 125000003282 alkyl amino group Chemical group 0.000 claims description 4
• 125000004104 aryloxy group Chemical group 0.000 claims description 4
• 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
• 125000004663 dialkyl amino group Chemical group 0.000 claims description 4
• 238000004519 manufacturing process Methods 0.000 claims description 4
• 108091008605 VEGF receptors Proteins 0.000 claims description 3
• 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 claims description 3
• 125000001153 fluoro group Chemical group F* 0.000 claims description 3
• 125000003107 substituted aryl group Chemical group 0.000 claims description 3
• 125000004442 acylamino group Chemical group 0.000 claims description 2
• 239000003085 diluting agent Substances 0.000 claims description 2
• 125000006574 non-aromatic ring group Chemical group 0.000 claims description 2
• 229910052703 rhodium Inorganic materials 0.000 claims description 2
• 125000006413 ring segment Chemical group 0.000 claims description 2
• 125000000547 substituted alkyl group Chemical group 0.000 claims description 2
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 7
• 150000002431 hydrogen Chemical group 0.000 claims 7
• 230000004614 tumor growth Effects 0.000 claims 1
• 238000000034 method Methods 0.000 abstract description 35
• 206010028980 Neoplasm Diseases 0.000 abstract description 30
• 201000011510 cancer Diseases 0.000 abstract description 24
• 230000001225 therapeutic effect Effects 0.000 abstract description 7
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract description 5
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract description 5
• 201000004681 Psoriasis Diseases 0.000 abstract description 4
• 206010039073 rheumatoid arthritis Diseases 0.000 abstract description 4
• 230000019491 signal transduction Effects 0.000 abstract description 3
• 206010012689 Diabetic retinopathy Diseases 0.000 abstract description 2
• 208000010412 Glaucoma Diseases 0.000 abstract description 2
• 201000003142 neovascular glaucoma Diseases 0.000 abstract description 2
• 230000000069 prophylactic effect Effects 0.000 abstract description 2
• 230000004663 cell proliferation Effects 0.000 abstract 2
• 238000005481 NMR spectroscopy Methods 0.000 description 159
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 98
• OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 86
• 239000000243 solution Substances 0.000 description 84
• 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 55
• 229910001868 water Inorganic materials 0.000 description 53
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 51
• 210000004027 cell Anatomy 0.000 description 47
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 46
• 238000006243 chemical reaction Methods 0.000 description 43
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 40
• 239000002904 solvent Substances 0.000 description 40
• 235000019439 ethyl acetate Nutrition 0.000 description 39
• 238000005160 1H NMR spectroscopy Methods 0.000 description 37
• 239000003795 chemical substances by application Substances 0.000 description 34
• 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 34
• 239000000203 mixture Substances 0.000 description 33
• CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 32
• 238000003556 assay Methods 0.000 description 32
• VEUMBMHMMCOFAG-UHFFFAOYSA-N 2,3-dihydrooxadiazole Chemical compound N1NC=CO1 VEUMBMHMMCOFAG-UHFFFAOYSA-N 0.000 description 30
• 230000005764 inhibitory process Effects 0.000 description 30
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 24
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 24
• IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 23
• 108091000080 Phosphotransferase Proteins 0.000 description 21
• CSCPPACGZOOCGX-WFGJKAKNSA-N acetone d6 Chemical compound [2H]C([2H])([2H])C(=O)C([2H])([2H])[2H] CSCPPACGZOOCGX-WFGJKAKNSA-N 0.000 description 21
• 102000020233 phosphotransferase Human genes 0.000 description 21
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 20
• 239000002253 acid Substances 0.000 description 19
• 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 18
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 18
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
• 229940093499 ethyl acetate Drugs 0.000 description 18
• 150000003839 salts Chemical class 0.000 description 18
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 17
• 239000007787 solid Substances 0.000 description 17
• GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 16
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 16
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 16
• 239000012267 brine Substances 0.000 description 16
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 16
• 238000012360 testing method Methods 0.000 description 16
• ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 15
• ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 15
• 102000013701 Cyclin-Dependent Kinase 4 Human genes 0.000 description 15
• 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 description 15
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 15
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 15
• VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
• HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 14
• DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 14
• 108091008794 FGF receptors Proteins 0.000 description 13
• 102000044168 Fibroblast Growth Factor Receptor Human genes 0.000 description 13
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 13
• 239000011541 reaction mixture Substances 0.000 description 13
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
• 101150041968 CDC13 gene Proteins 0.000 description 12
• TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 12
• 239000011230 binding agent Substances 0.000 description 12
• 108090000623 proteins and genes Proteins 0.000 description 12
• 239000011734 sodium Substances 0.000 description 12
• 238000011282 treatment Methods 0.000 description 12
• 102000016736 Cyclin Human genes 0.000 description 11
• 108050006400 Cyclin Proteins 0.000 description 11
• 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 description 11
• 102100036239 Cyclin-dependent kinase 2 Human genes 0.000 description 11
• 101000777293 Homo sapiens Serine/threonine-protein kinase Chk1 Proteins 0.000 description 11
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
• 239000003112 inhibitor Substances 0.000 description 11
• KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 10
• 102000004190 Enzymes Human genes 0.000 description 10
• 108090000790 Enzymes Proteins 0.000 description 10
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
• 150000001412 amines Chemical class 0.000 description 10
• 230000001413 cellular effect Effects 0.000 description 10
• 102000004169 proteins and genes Human genes 0.000 description 10
• 238000000746 purification Methods 0.000 description 10
• 102100022014 Angiopoietin-1 receptor Human genes 0.000 description 9
• 108091007914 CDKs Proteins 0.000 description 9
• 102100031081 Serine/threonine-protein kinase Chk1 Human genes 0.000 description 9
• 102100024036 Tyrosine-protein kinase Lck Human genes 0.000 description 9
• 239000000460 chlorine Substances 0.000 description 9
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
• 239000006184 cosolvent Substances 0.000 description 9
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 9
• 239000003921 oil Substances 0.000 description 9
• 235000019198 oils Nutrition 0.000 description 9
• 239000000843 powder Substances 0.000 description 9
• 230000008569 process Effects 0.000 description 9
• 235000018102 proteins Nutrition 0.000 description 9
• 230000002829 reductive effect Effects 0.000 description 9
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
• 238000004809 thin layer chromatography Methods 0.000 description 9
• XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 8
• 230000015572 biosynthetic process Effects 0.000 description 8
• 125000004432 carbon atom Chemical group C* 0.000 description 8
• 239000000969 carrier Substances 0.000 description 8
• 230000003197 catalytic effect Effects 0.000 description 8
• 239000007924 injection Substances 0.000 description 8
• 238000002347 injection Methods 0.000 description 8
• 239000007788 liquid Substances 0.000 description 8
• 235000019341 magnesium sulphate Nutrition 0.000 description 8
• 210000001525 retina Anatomy 0.000 description 8
• 235000017557 sodium bicarbonate Nutrition 0.000 description 8
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 8
• 238000003756 stirring Methods 0.000 description 8
• 101000878536 Homo sapiens Focal adhesion kinase 1 Proteins 0.000 description 7
• 102000013009 Pyruvate Kinase Human genes 0.000 description 7
• 108020005115 Pyruvate Kinase Proteins 0.000 description 7
• 239000002775 capsule Substances 0.000 description 7
• 238000011161 development Methods 0.000 description 7
• 230000018109 developmental process Effects 0.000 description 7
• 238000001914 filtration Methods 0.000 description 7
• 239000003102 growth factor Substances 0.000 description 7
• 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 7
• BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 7
• 239000000725 suspension Substances 0.000 description 7
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 6
• 102000002554 Cyclin A Human genes 0.000 description 6
• 108010068192 Cyclin A Proteins 0.000 description 6
• 102000003903 Cyclin-dependent kinases Human genes 0.000 description 6
• 108090000266 Cyclin-dependent kinases Proteins 0.000 description 6
• 102100037813 Focal adhesion kinase 1 Human genes 0.000 description 6
• 108010010803 Gelatin Proteins 0.000 description 6
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
• 206010053317 Hydrophobia Diseases 0.000 description 6
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
• 235000001014 amino acid Nutrition 0.000 description 6
• 150000001413 amino acids Chemical class 0.000 description 6
• 239000002585 base Substances 0.000 description 6
• 238000009472 formulation Methods 0.000 description 6
• 229920000159 gelatin Polymers 0.000 description 6
• 239000008273 gelatin Substances 0.000 description 6
• 235000019322 gelatine Nutrition 0.000 description 6
• 235000011852 gelatine desserts Nutrition 0.000 description 6
• 238000002000 high resolution fast-atom bombardment mass spectrometry Methods 0.000 description 6
• 229910001629 magnesium chloride Inorganic materials 0.000 description 6
• 239000000463 material Substances 0.000 description 6
• 239000002609 medium Substances 0.000 description 6
• 239000012071 phase Substances 0.000 description 6
• 229920001223 polyethylene glycol Polymers 0.000 description 6
• 239000000047 product Substances 0.000 description 6
• 230000001105 regulatory effect Effects 0.000 description 6
• 239000007858 starting material Substances 0.000 description 6
• 239000000758 substrate Substances 0.000 description 6
• 241000701447 unidentified baculovirus Species 0.000 description 6
• XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 5
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
• 241000124008 Mammalia Species 0.000 description 5
• 239000007864 aqueous solution Substances 0.000 description 5
• 230000035578 autophosphorylation Effects 0.000 description 5
• 230000022131 cell cycle Effects 0.000 description 5
• 230000006369 cell cycle progression Effects 0.000 description 5
• 239000003814 drug Substances 0.000 description 5
• 238000010828 elution Methods 0.000 description 5
• 125000000524 functional group Chemical group 0.000 description 5
• 235000003642 hunger Nutrition 0.000 description 5
• 239000008101 lactose Substances 0.000 description 5
• 230000001404 mediated effect Effects 0.000 description 5
• OKKJLVBELUTLKV-VMNATFBRSA-N methanol-d1 Chemical compound [2H]OC OKKJLVBELUTLKV-VMNATFBRSA-N 0.000 description 5
• DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 5
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 5
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 5
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 5
• 108090000765 processed proteins & peptides Proteins 0.000 description 5
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
• 239000000377 silicon dioxide Substances 0.000 description 5
• 230000037351 starvation Effects 0.000 description 5
• 210000001519 tissue Anatomy 0.000 description 5
• KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 4
• 101150050673 CHK1 gene Proteins 0.000 description 4
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
• 102000006313 Cyclin D3 Human genes 0.000 description 4
• 230000005778 DNA damage Effects 0.000 description 4
• 231100000277 DNA damage Toxicity 0.000 description 4
• 230000012746 DNA damage checkpoint Effects 0.000 description 4
• 241000238631 Hexapoda Species 0.000 description 4
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
• 108700020796 Oncogene Proteins 0.000 description 4
• 239000002202 Polyethylene glycol Substances 0.000 description 4
• 241000700159 Rattus Species 0.000 description 4
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
• 229920002472 Starch Polymers 0.000 description 4
• 238000002835 absorbance Methods 0.000 description 4
• 230000009471 action Effects 0.000 description 4
• 239000013543 active substance Substances 0.000 description 4
• 229940024606 amino acid Drugs 0.000 description 4
• 229910052786 argon Inorganic materials 0.000 description 4
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
• 150000004657 carbamic acid derivatives Chemical class 0.000 description 4
• 238000004587 chromatography analysis Methods 0.000 description 4
• QTMDXZNDVAMKGV-UHFFFAOYSA-L copper(ii) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 description 4
• 239000008298 dragée Substances 0.000 description 4
• 229940079593 drug Drugs 0.000 description 4
• 239000001963 growth medium Substances 0.000 description 4
• 230000003834 intracellular effect Effects 0.000 description 4
• 229910052740 iodine Inorganic materials 0.000 description 4
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
• 150000007524 organic acids Chemical class 0.000 description 4
• 239000001301 oxygen Chemical group 0.000 description 4
• NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 4
• 239000000741 silica gel Substances 0.000 description 4
• 229910002027 silica gel Inorganic materials 0.000 description 4
• 229960001866 silicon dioxide Drugs 0.000 description 4
• 229910052938 sodium sulfate Inorganic materials 0.000 description 4
• 235000011152 sodium sulphate Nutrition 0.000 description 4
• 239000003381 stabilizer Substances 0.000 description 4
• 239000000126 substance Substances 0.000 description 4
• 125000001424 substituent group Chemical group 0.000 description 4
• 235000000346 sugar Nutrition 0.000 description 4
• 238000013268 sustained release Methods 0.000 description 4
• 239000012730 sustained-release form Substances 0.000 description 4
• 238000003786 synthesis reaction Methods 0.000 description 4
• 230000002792 vascular Effects 0.000 description 4
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
• VFMGOJUUTAPPDA-UHFFFAOYSA-N 2-ethyl-5-methylpyrazole-3-carboxylic acid Chemical compound CCN1N=C(C)C=C1C(O)=O VFMGOJUUTAPPDA-UHFFFAOYSA-N 0.000 description 3
• VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 3
• ZFOXYMYPSAEQEA-UHFFFAOYSA-N 4-amino-2-(4-sulfamoylanilino)-1,3-thiazole-5-carbothioamide Chemical compound NC1=C(C(=S)N)SC(NC=2C=CC(=CC=2)S(N)(=O)=O)=N1 ZFOXYMYPSAEQEA-UHFFFAOYSA-N 0.000 description 3
• QZLSBOVWPHXCLT-UHFFFAOYSA-N 5-chlorothiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC=C(Cl)S1 QZLSBOVWPHXCLT-UHFFFAOYSA-N 0.000 description 3
• WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
• 240000003291 Armoracia rusticana Species 0.000 description 3
• 235000011330 Armoracia rusticana Nutrition 0.000 description 3
• 108010058545 Cyclin D3 Proteins 0.000 description 3
• 102100032857 Cyclin-dependent kinase 1 Human genes 0.000 description 3
• 101710106279 Cyclin-dependent kinase 1 Proteins 0.000 description 3
• RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 3
• 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 3
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 3
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
• 102000009465 Growth Factor Receptors Human genes 0.000 description 3
• 108010009202 Growth Factor Receptors Proteins 0.000 description 3
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
• MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
• OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• 108050002653 Retinoblastoma protein Proteins 0.000 description 3
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
• KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
• 229930006000 Sucrose Natural products 0.000 description 3
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
• 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 3
• 230000004913 activation Effects 0.000 description 3
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
• JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
• 229910052794 bromium Inorganic materials 0.000 description 3
• 239000003153 chemical reaction reagent Substances 0.000 description 3
• 229910052801 chlorine Inorganic materials 0.000 description 3
• 239000013078 crystal Substances 0.000 description 3
• 239000002552 dosage form Substances 0.000 description 3
• 229940035423 ethyl ether Drugs 0.000 description 3
• 239000000706 filtrate Substances 0.000 description 3
• 229910052731 fluorine Inorganic materials 0.000 description 3
• 239000007789 gas Substances 0.000 description 3
• 239000007903 gelatin capsule Substances 0.000 description 3
• 229910052736 halogen Inorganic materials 0.000 description 3
• 150000002367 halogens Chemical class 0.000 description 3
• 238000010438 heat treatment Methods 0.000 description 3
• 238000004128 high performance liquid chromatography Methods 0.000 description 3
• 238000013537 high throughput screening Methods 0.000 description 3
• 229910000037 hydrogen sulfide Inorganic materials 0.000 description 3
• 238000005462 in vivo assay Methods 0.000 description 3
• 150000007529 inorganic bases Chemical class 0.000 description 3
• 229940043355 kinase inhibitor Drugs 0.000 description 3
• 239000012044 organic layer Substances 0.000 description 3
• CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 3
• 230000003647 oxidation Effects 0.000 description 3
• 238000007254 oxidation reaction Methods 0.000 description 3
• KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
• 239000000546 pharmaceutical excipient Substances 0.000 description 3
• 229930029653 phosphoenolpyruvate Natural products 0.000 description 3
• 230000026731 phosphorylation Effects 0.000 description 3
• 238000006366 phosphorylation reaction Methods 0.000 description 3
• 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
• 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 3
• 229940068968 polysorbate 80 Drugs 0.000 description 3
• 229920000053 polysorbate 80 Polymers 0.000 description 3
• 239000002244 precipitate Substances 0.000 description 3
• 102000004196 processed proteins & peptides Human genes 0.000 description 3
• 150000003254 radicals Chemical class 0.000 description 3
• 238000010992 reflux Methods 0.000 description 3
• 230000004044 response Effects 0.000 description 3
• 230000002207 retinal effect Effects 0.000 description 3
• 238000004007 reversed phase HPLC Methods 0.000 description 3
• YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical class OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 3
• 229920006395 saturated elastomer Polymers 0.000 description 3
• 238000010898 silica gel chromatography Methods 0.000 description 3
• 239000011780 sodium chloride Substances 0.000 description 3
• 235000019698 starch Nutrition 0.000 description 3
• 238000006467 substitution reaction Methods 0.000 description 3
• 239000005720 sucrose Substances 0.000 description 3
• 150000008163 sugars Chemical class 0.000 description 3
• 239000004094 surface-active agent Substances 0.000 description 3
• 230000004083 survival effect Effects 0.000 description 3
• 239000006188 syrup Substances 0.000 description 3
• 235000020357 syrup Nutrition 0.000 description 3
• 239000003826 tablet Substances 0.000 description 3
• 231100000419 toxicity Toxicity 0.000 description 3
• 230000001988 toxicity Effects 0.000 description 3
• SEDZOYHHAIAQIW-UHFFFAOYSA-N trimethylsilyl azide Chemical compound C[Si](C)(C)N=[N+]=[N-] SEDZOYHHAIAQIW-UHFFFAOYSA-N 0.000 description 3
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
• 230000006459 vascular development Effects 0.000 description 3
• 210000004127 vitreous body Anatomy 0.000 description 3
• 229910052727 yttrium Inorganic materials 0.000 description 3
• TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical group C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 2
• LKUWQWDAIWXHIY-CHNJZELVSA-N (z)-2-methylbut-2-enoic acid Chemical compound C\C=C(\C)C(O)=O.C\C=C(\C)C(O)=O LKUWQWDAIWXHIY-CHNJZELVSA-N 0.000 description 2
• KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
• VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
• MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 description 2
• IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
• LVRFTAZAXQPQHI-UHFFFAOYSA-N 2-hydroxy-4-methylvaleric acid Chemical compound CC(C)CC(O)C(O)=O LVRFTAZAXQPQHI-UHFFFAOYSA-N 0.000 description 2
• CKQHAYFOPRIUOM-UHFFFAOYSA-N 3'-Aminoacetophenone Chemical compound CC(=O)C1=CC=CC(N)=C1 CKQHAYFOPRIUOM-UHFFFAOYSA-N 0.000 description 2
• NJXPYZHXZZCTNI-UHFFFAOYSA-N 3-aminobenzonitrile Chemical compound NC1=CC=CC(C#N)=C1 NJXPYZHXZZCTNI-UHFFFAOYSA-N 0.000 description 2
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
• HSZLBBZSPHXHDJ-UHFFFAOYSA-N 4-[(4-amino-5-cyano-1,3-thiazol-2-yl)amino]benzenesulfonamide Chemical compound S1C(C#N)=C(N)N=C1NC1=CC=C(S(N)(=O)=O)C=C1 HSZLBBZSPHXHDJ-UHFFFAOYSA-N 0.000 description 2
• KTBFNXHKAAHOFF-UHFFFAOYSA-N 4-amino-2-(tritylamino)-1,3-thiazole-5-carbothioamide Chemical compound NC1=C(C(=S)N)SC(NC(C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 KTBFNXHKAAHOFF-UHFFFAOYSA-N 0.000 description 2
• OMNHTTWQSSUZHO-UHFFFAOYSA-N 4-hydroxy-3,5-dimethylbenzoic acid Chemical compound CC1=CC(C(O)=O)=CC(C)=C1O OMNHTTWQSSUZHO-UHFFFAOYSA-N 0.000 description 2
• 229920001817 Agar Polymers 0.000 description 2
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
• 102100034594 Angiopoietin-1 Human genes 0.000 description 2
• 108010048154 Angiopoietin-1 Proteins 0.000 description 2
• 239000005711 Benzoic acid Substances 0.000 description 2
• BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
• 101150012716 CDK1 gene Proteins 0.000 description 2
• DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 description 2
• VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
• VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 2
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
• 229910021590 Copper(II) bromide Inorganic materials 0.000 description 2
• 102000002427 Cyclin B Human genes 0.000 description 2
• 108010068150 Cyclin B Proteins 0.000 description 2
• 102000003910 Cyclin D Human genes 0.000 description 2
• 108090000259 Cyclin D Proteins 0.000 description 2
• 108010025468 Cyclin-Dependent Kinase 6 Proteins 0.000 description 2
• 102100026804 Cyclin-dependent kinase 6 Human genes 0.000 description 2
• 101100481408 Danio rerio tie2 gene Proteins 0.000 description 2
• 101710088194 Dehydrogenase Proteins 0.000 description 2
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
• 238000004252 FT/ICR mass spectrometry Methods 0.000 description 2
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
• 230000010337 G2 phase Effects 0.000 description 2
• IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
• 108010052343 Gastrins Proteins 0.000 description 2
• DHCLVCXQIBBOPH-UHFFFAOYSA-N Glycerol 2-phosphate Chemical compound OCC(CO)OP(O)(O)=O DHCLVCXQIBBOPH-UHFFFAOYSA-N 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
• 101000753291 Homo sapiens Angiopoietin-1 receptor Proteins 0.000 description 2
• 101000715942 Homo sapiens Cyclin-dependent kinase 4 Proteins 0.000 description 2
• 101001047681 Homo sapiens Tyrosine-protein kinase Lck Proteins 0.000 description 2
• OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
• 229910021380 Manganese Chloride Inorganic materials 0.000 description 2
• GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 2
• YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
• 101100481410 Mus musculus Tek gene Proteins 0.000 description 2
• HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 2
• MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
• SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
• 239000007832 Na2SO4 Substances 0.000 description 2
• 239000000020 Nitrocellulose Substances 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
• 229910006074 SO2NH2 Inorganic materials 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
• 229910021626 Tin(II) chloride Chemical group 0.000 description 2
• GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
• 102000015098 Tumor Suppressor Protein p53 Human genes 0.000 description 2
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
• 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 description 2
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
• 150000007513 acids Chemical class 0.000 description 2
• 239000008272 agar Substances 0.000 description 2
• 235000010419 agar Nutrition 0.000 description 2
• 206010064930 age-related macular degeneration Diseases 0.000 description 2
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
• 125000000539 amino acid group Chemical group 0.000 description 2
• 230000002491 angiogenic effect Effects 0.000 description 2
• 238000003782 apoptosis assay Methods 0.000 description 2
• 230000006907 apoptotic process Effects 0.000 description 2
• 210000001742 aqueous humor Anatomy 0.000 description 2
• 239000008135 aqueous vehicle Substances 0.000 description 2
• OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 2
• 230000004888 barrier function Effects 0.000 description 2
• 229960004365 benzoic acid Drugs 0.000 description 2
• 125000001246 bromo group Chemical group Br* 0.000 description 2
• 239000000872 buffer Substances 0.000 description 2
• 229910002092 carbon dioxide Inorganic materials 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• 239000001768 carboxy methyl cellulose Substances 0.000 description 2
• 230000032823 cell division Effects 0.000 description 2
• 230000010261 cell growth Effects 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 235000010980 cellulose Nutrition 0.000 description 2
• MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
• 238000000576 coating method Methods 0.000 description 2
• 229910052681 coesite Inorganic materials 0.000 description 2
• 230000000875 corresponding effect Effects 0.000 description 2
• 229910052906 cristobalite Inorganic materials 0.000 description 2
• 239000012043 crude product Substances 0.000 description 2
• 230000006378 damage Effects 0.000 description 2
• 230000002950 deficient Effects 0.000 description 2
• 239000008121 dextrose Substances 0.000 description 2
• 150000004985 diamines Chemical class 0.000 description 2
• 238000001035 drying Methods 0.000 description 2
• 239000013604 expression vector Substances 0.000 description 2
• 238000000605 extraction Methods 0.000 description 2
• 238000003818 flash chromatography Methods 0.000 description 2
• 235000019253 formic acid Nutrition 0.000 description 2
• 239000012634 fragment Substances 0.000 description 2
• 239000012458 free base Substances 0.000 description 2
• 239000000499 gel Substances 0.000 description 2
• 230000014509 gene expression Effects 0.000 description 2
• 229930195712 glutamate Natural products 0.000 description 2
• 125000000623 heterocyclic group Chemical group 0.000 description 2
• 102000048992 human CDK4 Human genes 0.000 description 2
• 102000048620 human CHEK1 Human genes 0.000 description 2
• XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
• 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
• 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
• 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
• 102000006495 integrins Human genes 0.000 description 2
• 108010044426 integrins Proteins 0.000 description 2
• 230000003993 interaction Effects 0.000 description 2
• WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical compound CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 description 2
• 239000002502 liposome Substances 0.000 description 2
• ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
• 231100000053 low toxicity Toxicity 0.000 description 2
• 208000002780 macular degeneration Diseases 0.000 description 2
• 239000011565 manganese chloride Substances 0.000 description 2
• 235000002867 manganese chloride Nutrition 0.000 description 2
• 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 2
• 239000012528 membrane Substances 0.000 description 2
• 150000007522 mineralic acids Chemical class 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
• DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 description 2
• 229920001220 nitrocellulos Polymers 0.000 description 2
• 150000007530 organic bases Chemical class 0.000 description 2
• 239000003960 organic solvent Substances 0.000 description 2
• WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 2
• ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
• 230000037361 pathway Effects 0.000 description 2
• 235000021317 phosphate Nutrition 0.000 description 2
• LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical group [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 2
• 239000003757 phosphotransferase inhibitor Substances 0.000 description 2
• 229940068886 polyethylene glycol 300 Drugs 0.000 description 2
• 229920000642 polymer Polymers 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• 230000005522 programmed cell death Effects 0.000 description 2
• 239000003909 protein kinase inhibitor Substances 0.000 description 2
• 125000004076 pyridyl group Chemical group 0.000 description 2
• 108091008598 receptor tyrosine kinases Proteins 0.000 description 2
• 102000027426 receptor tyrosine kinases Human genes 0.000 description 2
• 238000011160 research Methods 0.000 description 2
• 238000012216 screening Methods 0.000 description 2
• 235000012239 silicon dioxide Nutrition 0.000 description 2
• 229910052708 sodium Inorganic materials 0.000 description 2
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
• PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
• 238000001228 spectrum Methods 0.000 description 2
• 239000001119 stannous chloride Chemical group 0.000 description 2
• 235000011150 stannous chloride Nutrition 0.000 description 2
• 229910052682 stishovite Inorganic materials 0.000 description 2
• 108010065665 syntide-2 Proteins 0.000 description 2
• 238000007910 systemic administration Methods 0.000 description 2
• 239000000454 talc Substances 0.000 description 2
• 229910052623 talc Inorganic materials 0.000 description 2
• 235000012222 talc Nutrition 0.000 description 2
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 230000007704 transition Effects 0.000 description 2
• 229910052905 tridymite Inorganic materials 0.000 description 2
• 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 2
• 239000013598 vector Substances 0.000 description 2
• 238000010626 work up procedure Methods 0.000 description 2
• 239000008096 xylene Substances 0.000 description 2
• 150000003738 xylenes Chemical class 0.000 description 2
• QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
• NKBRRWBNPNUBDD-TYKVATLISA-N (2s)-6-amino-2-[[(2s)-6-amino-2-[[2-[[(2s)-1-[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s,3r)-2-[[(2s)-5-(diaminomethylideneamino)-2-[[(2s)-2-[[(2s)-4-methyl-2-[[(2s)-pyrrolidine-2-carbonyl]amino]pentanoyl]amino]propanoyl]amino]pentanoyl]amino]-3 Chemical compound N([C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O)[C@@H](C)O)C(=O)[C@@H]1CCCN1 NKBRRWBNPNUBDD-TYKVATLISA-N 0.000 description 1
• QQGISFDJEJMKIL-JAIQZWGSSA-N (5z)-5-[[3-(hydroxymethyl)thiophen-2-yl]methylidene]-10-methoxy-2,2,4-trimethyl-1h-chromeno[3,4-f]quinolin-9-ol Chemical compound C1=CC=2NC(C)(C)C=C(C)C=2C2=C1C=1C(OC)=C(O)C=CC=1O\C2=C/C=1SC=CC=1CO QQGISFDJEJMKIL-JAIQZWGSSA-N 0.000 description 1
• WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
• 125000004529 1,2,3-triazinyl group Chemical group N1=NN=C(C=C1)* 0.000 description 1
• 125000004505 1,2,4-oxadiazol-5-yl group Chemical group O1N=CN=C1* 0.000 description 1
• 125000004504 1,2,4-oxadiazolyl group Chemical group 0.000 description 1
• DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
• 125000001781 1,3,4-oxadiazolyl group Chemical group 0.000 description 1
• LQQKDSXCDXHLLF-UHFFFAOYSA-N 1,3-dibromopropan-2-one Chemical compound BrCC(=O)CBr LQQKDSXCDXHLLF-UHFFFAOYSA-N 0.000 description 1
• QHHHLHCCVDMOJI-UHFFFAOYSA-N 1,3-thiazol-4-amine Chemical compound NC1=CSC=N1 QHHHLHCCVDMOJI-UHFFFAOYSA-N 0.000 description 1
• XWXPRCDFFCVMNT-UHFFFAOYSA-N 1,3-thiazole-5-carbonitrile Chemical compound N#CC1=CN=CS1 XWXPRCDFFCVMNT-UHFFFAOYSA-N 0.000 description 1
• CGXJUBDTCAAXAY-UHFFFAOYSA-N 1-(3-aminophenyl)propan-1-one Chemical compound CCC(=O)C1=CC=CC(N)=C1 CGXJUBDTCAAXAY-UHFFFAOYSA-N 0.000 description 1
• IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
• MQGBARXPCXAFRZ-UHFFFAOYSA-N 2,4-dimethyl-1,3-thiazole-5-carboxylic acid Chemical compound CC1=NC(C)=C(C(O)=O)S1 MQGBARXPCXAFRZ-UHFFFAOYSA-N 0.000 description 1
• SPMLMLQATWNZEE-UHFFFAOYSA-N 2-(chloromethyl)-1h-benzimidazole Chemical compound C1=CC=C2NC(CCl)=NC2=C1 SPMLMLQATWNZEE-UHFFFAOYSA-N 0.000 description 1
• BWCCPOQIMGGGQX-UHFFFAOYSA-N 2-(chloromethyl)-4,6-dimethoxypyrimidine Chemical compound COC1=CC(OC)=NC(CCl)=N1 BWCCPOQIMGGGQX-UHFFFAOYSA-N 0.000 description 1
• XOVKMILMYFEUMK-UHFFFAOYSA-N 2-(chloromethyl)-5-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(CCl)N=C1 XOVKMILMYFEUMK-UHFFFAOYSA-N 0.000 description 1
• WZEWEZMUYDNMCZ-UHFFFAOYSA-N 2-(chloromethyl)-6-methoxy-1h-benzimidazole Chemical compound COC1=CC=C2N=C(CCl)NC2=C1 WZEWEZMUYDNMCZ-UHFFFAOYSA-N 0.000 description 1
• NJWIMFZLESWFIM-UHFFFAOYSA-N 2-(chloromethyl)pyridine Chemical compound ClCC1=CC=CC=N1 NJWIMFZLESWFIM-UHFFFAOYSA-N 0.000 description 1
• JPMRGPPMXHGKRO-UHFFFAOYSA-N 2-(chloromethyl)pyridine hydrochloride Chemical compound Cl.ClCC1=CC=CC=N1 JPMRGPPMXHGKRO-UHFFFAOYSA-N 0.000 description 1
• DDEAEWMDOSXKBX-UHFFFAOYSA-N 2-(chloromethyl)quinoline Chemical compound C1=CC=CC2=NC(CCl)=CC=C21 DDEAEWMDOSXKBX-UHFFFAOYSA-N 0.000 description 1
• NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
• PPBUGVXKMDIXGZ-UHFFFAOYSA-N 2-[4-amino-2-(4-sulfamoylanilino)-1,3-thiazol-5-yl]-n-methoxy-n-methyl-1,3-thiazole-4-carboxamide Chemical compound CON(C)C(=O)C1=CSC(C2=C(N=C(NC=3C=CC(=CC=3)S(N)(=O)=O)S2)N)=N1 PPBUGVXKMDIXGZ-UHFFFAOYSA-N 0.000 description 1
• REXUYBKPWIPONM-UHFFFAOYSA-N 2-bromoacetonitrile Chemical compound BrCC#N REXUYBKPWIPONM-UHFFFAOYSA-N 0.000 description 1
• 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
• IKCLCGXPQILATA-UHFFFAOYSA-N 2-chlorobenzoic acid Chemical class OC(=O)C1=CC=CC=C1Cl IKCLCGXPQILATA-UHFFFAOYSA-N 0.000 description 1
• BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
• KGGHWIKBOIQEAJ-UHFFFAOYSA-N 2-fluorobenzamide Chemical compound NC(=O)C1=CC=CC=C1F KGGHWIKBOIQEAJ-UHFFFAOYSA-N 0.000 description 1
• 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
• HBAHZZVIEFRTEY-UHFFFAOYSA-N 2-heptylcyclohex-2-en-1-one Chemical compound CCCCCCCC1=CCCCC1=O HBAHZZVIEFRTEY-UHFFFAOYSA-N 0.000 description 1
• 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
• HZLCGUXUOFWCCN-UHFFFAOYSA-N 2-hydroxynonadecane-1,2,3-tricarboxylic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)C(O)(C(O)=O)CC(O)=O HZLCGUXUOFWCCN-UHFFFAOYSA-N 0.000 description 1
• GCKYUSVGXDHLIA-UHFFFAOYSA-N 2-n-[4-(dimethylamino)phenyl]-5-(2h-tetrazol-5-yl)-1,3-thiazole-2,4-diamine Chemical compound C1=CC(N(C)C)=CC=C1NC1=NC(N)=C(C2=NNN=N2)S1 GCKYUSVGXDHLIA-UHFFFAOYSA-N 0.000 description 1
• GILCFOZQOQMDFK-UHFFFAOYSA-N 2-n-phenyl-5-pyridin-2-yl-1,3-thiazole-2,4-diamine Chemical compound S1C(C=2N=CC=CC=2)=C(N)N=C1NC1=CC=CC=C1 GILCFOZQOQMDFK-UHFFFAOYSA-N 0.000 description 1
• 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
• MAGGXASHVAMJCT-UHFFFAOYSA-N 3-(bromomethyl)-6,7-dimethoxy-1-methylquinoxalin-2-one Chemical compound N1=C(CBr)C(=O)N(C)C2=C1C=C(OC)C(OC)=C2 MAGGXASHVAMJCT-UHFFFAOYSA-N 0.000 description 1
• RSSBMWQNIDHJNS-UHFFFAOYSA-N 3-(chloromethyl)-5-(thiadiazol-4-yl)-1,2,4-oxadiazole Chemical compound ClCC1=NOC(C=2N=NSC=2)=N1 RSSBMWQNIDHJNS-UHFFFAOYSA-N 0.000 description 1
• GDSRCDDMXXHAJM-UHFFFAOYSA-N 3-[2-[4-amino-2-(3,4,5-trimethoxyanilino)-1,3-thiazol-5-yl]-1,3-thiazol-4-yl]-4-bromophenol Chemical compound COC1=C(OC)C(OC)=CC(NC=2SC(=C(N)N=2)C=2SC=C(N=2)C=2C(=CC=C(O)C=2)Br)=C1 GDSRCDDMXXHAJM-UHFFFAOYSA-N 0.000 description 1
• MCANOSCFLJPTSA-UHFFFAOYSA-N 3-[2-[4-amino-2-(3,4,5-trimethoxyanilino)-1,3-thiazol-5-yl]-1,3-thiazol-4-yl]-n-(3-methyl-4-propan-2-ylphenyl)benzamide Chemical compound COC1=C(OC)C(OC)=CC(NC=2SC(=C(N)N=2)C=2SC=C(N=2)C=2C=C(C=CC=2)C(=O)NC=2C=C(C)C(C(C)C)=CC=2)=C1 MCANOSCFLJPTSA-UHFFFAOYSA-N 0.000 description 1
• HVIXUZWSUKWBCK-UHFFFAOYSA-N 3-[2-[4-amino-2-(3,4,5-trimethoxyanilino)-1,3-thiazol-5-yl]-1,3-thiazol-4-yl]phenol Chemical compound COC1=C(OC)C(OC)=CC(NC=2SC(=C(N)N=2)C=2SC=C(N=2)C=2C=C(O)C=CC=2)=C1 HVIXUZWSUKWBCK-UHFFFAOYSA-N 0.000 description 1
• FKXUTRIRDQHANY-UHFFFAOYSA-N 3-amino-4-[5-[4-amino-2-(3,4,5-trimethoxyanilino)-1,3-thiazol-5-yl]-1,2,4-oxadiazol-3-yl]-2-phenylmethoxybenzoic acid Chemical compound COC1=C(OC)C(OC)=CC(NC=2SC(=C(N)N=2)C=2ON=C(N=2)C=2C(=C(OCC=3C=CC=CC=3)C(C(O)=O)=CC=2)N)=C1 FKXUTRIRDQHANY-UHFFFAOYSA-N 0.000 description 1
• BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
• PRRZDZJYSJLDBS-UHFFFAOYSA-N 3-bromo-2-oxopropanoic acid Chemical compound OC(=O)C(=O)CBr PRRZDZJYSJLDBS-UHFFFAOYSA-N 0.000 description 1
• 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
• PPLLAHQNNDKXJU-UHFFFAOYSA-N 3-chloropyridine-4-carboxamide Chemical compound NC(=O)C1=CC=NC=C1Cl PPLLAHQNNDKXJU-UHFFFAOYSA-N 0.000 description 1
• BXEAAHIHFFIMIE-UHFFFAOYSA-N 3-chlorothiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC=CC=1Cl BXEAAHIHFFIMIE-UHFFFAOYSA-N 0.000 description 1
• KKFQIFLHVDGQIW-UHFFFAOYSA-N 3-cyano-n-[(2-methylpropan-2-yl)oxy]benzamide Chemical compound CC(C)(C)ONC(=O)C1=CC=CC(C#N)=C1 KKFQIFLHVDGQIW-UHFFFAOYSA-N 0.000 description 1
• QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
• VKPLPDIMEREJJF-UHFFFAOYSA-N 3-methoxybenzamide Chemical compound COC1=CC=CC(C(N)=O)=C1 VKPLPDIMEREJJF-UHFFFAOYSA-N 0.000 description 1
• UEJQTBKTWJQBRN-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-chlorophenyl)-1,3-thiazole Chemical compound ClCC1=CSC(C=2C=CC(Cl)=CC=2)=N1 UEJQTBKTWJQBRN-UHFFFAOYSA-N 0.000 description 1
• VCTKYTBWZTZPHF-UHFFFAOYSA-N 4-(chloromethyl)-5-methyl-2-phenyl-1,3-oxazole Chemical compound ClCC1=C(C)OC(C=2C=CC=CC=2)=N1 VCTKYTBWZTZPHF-UHFFFAOYSA-N 0.000 description 1
• MDHSMURQEIBQCD-UHFFFAOYSA-N 4-[2-[4-amino-2-(3,4,5-trimethoxyanilino)-1,3-thiazol-5-yl]-1,3-thiazol-4-yl]-2-methoxyphenol Chemical compound C1=C(O)C(OC)=CC(C=2N=C(SC=2)C2=C(N=C(NC=3C=C(OC)C(OC)=C(OC)C=3)S2)N)=C1 MDHSMURQEIBQCD-UHFFFAOYSA-N 0.000 description 1
• RCLWZOPSEAIENH-UHFFFAOYSA-N 4-[2-[4-amino-2-(3,4,5-trimethoxyanilino)-1,3-thiazol-5-yl]-1,3-thiazol-4-yl]phenol Chemical compound COC1=C(OC)C(OC)=CC(NC=2SC(=C(N)N=2)C=2SC=C(N=2)C=2C=CC(O)=CC=2)=C1 RCLWZOPSEAIENH-UHFFFAOYSA-N 0.000 description 1
• RPJMTTUATVKBMN-UHFFFAOYSA-N 4-[[4-amino-5-(4-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-2-yl]amino]benzenesulfonamide Chemical compound S1C(C=2SC=C(N=2)C=2C=CC=CC=2)=C(N)N=C1NC1=CC=C(S(N)(=O)=O)C=C1 RPJMTTUATVKBMN-UHFFFAOYSA-N 0.000 description 1
• JOYLNPOUQUOJQV-UHFFFAOYSA-N 4-[[4-amino-5-(5-nitro-1,3-benzothiazol-2-yl)-1,3-thiazol-2-yl]amino]benzenesulfonamide Chemical compound S1C(C=2SC3=CC=C(C=C3N=2)[N+]([O-])=O)=C(N)N=C1NC1=CC=C(S(N)(=O)=O)C=C1 JOYLNPOUQUOJQV-UHFFFAOYSA-N 0.000 description 1
• OSSNJSQSZXWTNG-UHFFFAOYSA-N 4-[[4-amino-5-[4-(2-methoxyphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]amino]benzenesulfonamide Chemical compound COC1=CC=CC=C1C1=CSC(C2=C(N=C(NC=3C=CC(=CC=3)S(N)(=O)=O)S2)N)=N1 OSSNJSQSZXWTNG-UHFFFAOYSA-N 0.000 description 1
• HYPQGOBVVRLGMX-UHFFFAOYSA-N 4-[[4-amino-5-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]amino]benzenesulfonamide Chemical compound S1C(C=2SC=C(N=2)C=2C=CC(F)=CC=2)=C(N)N=C1NC1=CC=C(S(N)(=O)=O)C=C1 HYPQGOBVVRLGMX-UHFFFAOYSA-N 0.000 description 1
• XZGVPALXXNPWAU-UHFFFAOYSA-N 4-[[4-amino-5-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]amino]benzenesulfonamide Chemical compound C1=CC(OC)=CC=C1C1=CSC(C2=C(N=C(NC=3C=CC(=CC=3)S(N)(=O)=O)S2)N)=N1 XZGVPALXXNPWAU-UHFFFAOYSA-N 0.000 description 1
• SBPYFSNOCLTFHC-UHFFFAOYSA-N 4-[[4-amino-5-[4-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]amino]benzenesulfonamide Chemical compound C1=CC(C)=CC=C1C1=CSC(C2=C(N=C(NC=3C=CC(=CC=3)S(N)(=O)=O)S2)N)=N1 SBPYFSNOCLTFHC-UHFFFAOYSA-N 0.000 description 1
• GYYDOTRVYWUEPZ-UHFFFAOYSA-N 4-[[4-amino-5-[4-[2-(3-hydroxy-4-methoxyphenyl)ethenyl]-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]amino]benzenesulfonamide Chemical compound C1=C(O)C(OC)=CC=C1C=CC1=CSC(C2=C(N=C(NC=3C=CC(=CC=3)S(N)(=O)=O)S2)N)=N1 GYYDOTRVYWUEPZ-UHFFFAOYSA-N 0.000 description 1
• XPXLWEBNQPZCBC-UHFFFAOYSA-N 4-amino-2-(3,4,5-trimethoxyanilino)-1,3-thiazole-5-carbonitrile Chemical compound COC1=C(OC)C(OC)=CC(NC=2SC(=C(N)N=2)C#N)=C1 XPXLWEBNQPZCBC-UHFFFAOYSA-N 0.000 description 1
• WSVCIWJKLYVDLA-UHFFFAOYSA-N 4-amino-2-(4-propan-2-ylanilino)-1,3-thiazole-5-carbothioamide Chemical compound C1=CC(C(C)C)=CC=C1NC1=NC(N)=C(C(N)=S)S1 WSVCIWJKLYVDLA-UHFFFAOYSA-N 0.000 description 1
• 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
• SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical class OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 description 1
• IMDUFDNFSJWYQT-UHFFFAOYSA-N 4-isothiocyanatobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=C(N=C=S)C=C1 IMDUFDNFSJWYQT-UHFFFAOYSA-N 0.000 description 1
• CRJMUPLBKOEEGR-UHFFFAOYSA-N 5-(3,4,5-trimethoxyphenyl)-1,3-thiazole-2,4-diamine Chemical compound COc1cc(cc(OC)c1OC)-c1sc(N)nc1N CRJMUPLBKOEEGR-UHFFFAOYSA-N 0.000 description 1
• HRSFRTHRNQEVAS-UHFFFAOYSA-N 5-(6-bromopyridin-2-yl)-2-n-(3,4,5-trimethoxyphenyl)-1,3-thiazole-2,4-diamine Chemical compound COC1=C(OC)C(OC)=CC(NC=2SC(=C(N)N=2)C=2N=C(Br)C=CC=2)=C1 HRSFRTHRNQEVAS-UHFFFAOYSA-N 0.000 description 1
• NAGJNOJBNXYWAP-UHFFFAOYSA-N 5-(6-thiophen-3-ylpyridin-2-yl)-2-n-(3,4,5-trimethoxyphenyl)-1,3-thiazole-2,4-diamine Chemical compound COC1=C(OC)C(OC)=CC(NC=2SC(=C(N)N=2)C=2N=C(C=CC=2)C2=CSC=C2)=C1 NAGJNOJBNXYWAP-UHFFFAOYSA-N 0.000 description 1
• BJVYSQGEJHKTBW-UHFFFAOYSA-N 5-(chloromethyl)-3-(4-chlorophenyl)-1,2,4-oxadiazole Chemical compound O1C(CCl)=NC(C=2C=CC(Cl)=CC=2)=N1 BJVYSQGEJHKTBW-UHFFFAOYSA-N 0.000 description 1
• RYZHGEZWUMHELK-UHFFFAOYSA-N 5-(chloromethyl)-3-(4-chlorophenyl)-1h-1,2,4-triazole Chemical compound N1C(CCl)=NN=C1C1=CC=C(Cl)C=C1 RYZHGEZWUMHELK-UHFFFAOYSA-N 0.000 description 1
• KVFQFCXDQVNXDP-AWEZNQCLSA-N 5-[(4r)-4-phenyl-4,5-dihydro-1,3-oxazol-2-yl]-2-n-(3,4,5-trimethoxyphenyl)-1,3-thiazole-2,4-diamine Chemical compound COC1=C(OC)C(OC)=CC(NC=2SC(=C(N)N=2)C=2OC[C@H](N=2)C=2C=CC=CC=2)=C1 KVFQFCXDQVNXDP-AWEZNQCLSA-N 0.000 description 1
• COWZPSUDTMGBAT-UHFFFAOYSA-N 5-bromothiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC=C(Br)S1 COWZPSUDTMGBAT-UHFFFAOYSA-N 0.000 description 1
• FFFMIFUBJZBTCG-UHFFFAOYSA-N 5-chloro-3-(chloromethyl)-1,2,4-thiadiazole Chemical compound ClCC1=NSC(Cl)=N1 FFFMIFUBJZBTCG-UHFFFAOYSA-N 0.000 description 1
• AFWKAIYTSPWWCA-UHFFFAOYSA-N 5-isothiocyanato-1,2,3-trimethoxybenzene Chemical compound COC1=CC(N=C=S)=CC(OC)=C1OC AFWKAIYTSPWWCA-UHFFFAOYSA-N 0.000 description 1
• UYDGNRLMYZMDOG-UHFFFAOYSA-N 5-methyl-1,3-thiazole-2-carboxylic acid Chemical compound CC1=CN=C(C(O)=O)S1 UYDGNRLMYZMDOG-UHFFFAOYSA-N 0.000 description 1
• VCNGNQLPFHVODE-UHFFFAOYSA-N 5-methylthiophene-2-carboxylic acid Chemical compound CC1=CC=C(C(O)=O)S1 VCNGNQLPFHVODE-UHFFFAOYSA-N 0.000 description 1
• RUKDIKJSGDVSIF-UHFFFAOYSA-N 5-phenyl-1,3-oxazole-4-carboxylic acid Chemical compound N1=COC(C=2C=CC=CC=2)=C1C(=O)O RUKDIKJSGDVSIF-UHFFFAOYSA-N 0.000 description 1
• CWDWFSXUQODZGW-UHFFFAOYSA-N 5-thiazolyl Chemical group [C]1=CN=CS1 CWDWFSXUQODZGW-UHFFFAOYSA-N 0.000 description 1
• ZKCAVUYFKJKMRI-UHFFFAOYSA-N 6-(chloromethyl)-2-propan-2-yl-1h-pyrimidin-4-one Chemical compound CC(C)C1=NC(=O)C=C(CCl)N1 ZKCAVUYFKJKMRI-UHFFFAOYSA-N 0.000 description 1
• ZLKMOIHCHCMSFW-UHFFFAOYSA-N 6-chloropyridine-2-carboxylic acid Chemical compound OC(=O)C1=CC=CC(Cl)=N1 ZLKMOIHCHCMSFW-UHFFFAOYSA-N 0.000 description 1
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
• 244000215068 Acacia senegal Species 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• 102100034608 Angiopoietin-2 Human genes 0.000 description 1
• 108010048036 Angiopoietin-2 Proteins 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 206010003210 Arteriosclerosis Diseases 0.000 description 1
• 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
• FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
• QTNPDLDEXABDMI-UHFFFAOYSA-N C1=C(C(O)=O)C(CC)=CC(NC=2SC(=C(N)N=2)C=2SC=C(N=2)C=2C=C(NC(=O)C=3C=CC=CC=3)C=CC=2)=C1 Chemical compound C1=C(C(O)=O)C(CC)=CC(NC=2SC(=C(N)N=2)C=2SC=C(N=2)C=2C=C(NC(=O)C=3C=CC=CC=3)C=CC=2)=C1 QTNPDLDEXABDMI-UHFFFAOYSA-N 0.000 description 1
• 101100273797 Caenorhabditis elegans pct-1 gene Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
• 208000005623 Carcinogenesis Diseases 0.000 description 1
• 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
• 108010019244 Checkpoint Kinase 1 Proteins 0.000 description 1
• 102000006459 Checkpoint Kinase 1 Human genes 0.000 description 1
• KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
• WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
• 229920002261 Corn starch Polymers 0.000 description 1
• 108010025454 Cyclin-Dependent Kinase 5 Proteins 0.000 description 1
• 102100026805 Cyclin-dependent-like kinase 5 Human genes 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• 239000012623 DNA damaging agent Substances 0.000 description 1
• 230000033616 DNA repair Effects 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 238000002965 ELISA Methods 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
• 101100059559 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) nimX gene Proteins 0.000 description 1
• 101100001671 Emericella variicolor andF gene Proteins 0.000 description 1
• 241000588724 Escherichia coli Species 0.000 description 1
• VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
• 239000001856 Ethyl cellulose Substances 0.000 description 1
• ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
• 239000005977 Ethylene Substances 0.000 description 1
• 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
• 102100031706 Fibroblast growth factor 1 Human genes 0.000 description 1
• PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
• 108010067715 Focal Adhesion Protein-Tyrosine Kinases Proteins 0.000 description 1
• 102000016621 Focal Adhesion Protein-Tyrosine Kinases Human genes 0.000 description 1
• 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
• 230000037060 G2 phase arrest Effects 0.000 description 1
• 208000031448 Genomic Instability Diseases 0.000 description 1
• YSWHPLCDIMUKFE-QWRGUYRKSA-N Glu-Tyr Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 YSWHPLCDIMUKFE-QWRGUYRKSA-N 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 102000005720 Glutathione transferase Human genes 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 229920000084 Gum arabic Polymers 0.000 description 1
• 239000007821 HATU Substances 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101000738559 Homo sapiens G1/S-specific cyclin-D3 Proteins 0.000 description 1
• 101000988802 Homo sapiens Hematopoietic prostaglandin D synthase Proteins 0.000 description 1
• 101000632319 Homo sapiens Septin-7 Proteins 0.000 description 1
• 101000777277 Homo sapiens Serine/threonine-protein kinase Chk2 Proteins 0.000 description 1
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
• AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
• 206010058490 Hyperoxia Diseases 0.000 description 1
• 206010021143 Hypoxia Diseases 0.000 description 1
• 208000007766 Kaposi sarcoma Diseases 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• 240000007472 Leucaena leucocephala Species 0.000 description 1
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
• 235000019759 Maize starch Nutrition 0.000 description 1
• PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 229920001367 Merrifield resin Polymers 0.000 description 1
• VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
• JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 1
• 206010029113 Neovascularisation Diseases 0.000 description 1
• GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
• ILUJQPXNXACGAN-UHFFFAOYSA-N O-methylsalicylic acid Chemical class COC1=CC=CC=C1C(O)=O ILUJQPXNXACGAN-UHFFFAOYSA-N 0.000 description 1
• 208000022873 Ocular disease Diseases 0.000 description 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
• 108010058846 Ovalbumin Proteins 0.000 description 1
• NHJSWORVNIOXIT-UHFFFAOYSA-N PD-166866 Chemical compound COC1=CC(OC)=CC(C=2C(=NC3=NC(N)=NC=C3C=2)NC(=O)NC(C)(C)C)=C1 NHJSWORVNIOXIT-UHFFFAOYSA-N 0.000 description 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
• 235000019483 Peanut oil Nutrition 0.000 description 1
• 102000003992 Peroxidases Human genes 0.000 description 1
• IGVPBCZDHMIOJH-UHFFFAOYSA-N Phenyl butyrate Chemical class CCCC(=O)OC1=CC=CC=C1 IGVPBCZDHMIOJH-UHFFFAOYSA-N 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 206010036590 Premature baby Diseases 0.000 description 1
• XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
• 102000009516 Protein Serine-Threonine Kinases Human genes 0.000 description 1
• 108010009341 Protein Serine-Threonine Kinases Proteins 0.000 description 1
• IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
• 239000012980 RPMI-1640 medium Substances 0.000 description 1
• 108090000873 Receptor Protein-Tyrosine Kinases Proteins 0.000 description 1
• 102000004278 Receptor Protein-Tyrosine Kinases Human genes 0.000 description 1
• 208000007135 Retinal Neovascularization Diseases 0.000 description 1
• 230000018199 S phase Effects 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 102100027981 Septin-7 Human genes 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 102100031075 Serine/threonine-protein kinase Chk2 Human genes 0.000 description 1
• 229920002125 Sokalan® Polymers 0.000 description 1
• 235000021355 Stearic acid Nutrition 0.000 description 1
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
• 210000001744 T-lymphocyte Anatomy 0.000 description 1
• FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• 102000016549 Vascular Endothelial Growth Factor Receptor-2 Human genes 0.000 description 1
• 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 1
• 101100273808 Xenopus laevis cdk1-b gene Proteins 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• SBUHQVXRSIMLCH-UHFFFAOYSA-N [2-(2,4-diamino-1,3-thiazol-5-yl)-1,3-thiazol-4-yl]-phenylmethanone Chemical compound S1C(N)=NC(N)=C1C1=NC(C(=O)C=2C=CC=CC=2)=CS1 SBUHQVXRSIMLCH-UHFFFAOYSA-N 0.000 description 1
• ZOCLVGHDXBVATF-UHFFFAOYSA-N [4-(2-aminoethoxy)-3,5-diiodophenyl]-(2-butyl-1-benzofuran-3-yl)methanone Chemical compound CCCCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(I)=C(OCCN)C(I)=C1 ZOCLVGHDXBVATF-UHFFFAOYSA-N 0.000 description 1
• 235000010489 acacia gum Nutrition 0.000 description 1
• 239000000205 acacia gum Substances 0.000 description 1
• 239000012445 acidic reagent Substances 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 208000038016 acute inflammation Diseases 0.000 description 1
• 230000006022 acute inflammation Effects 0.000 description 1
• 230000010933 acylation Effects 0.000 description 1
• 238000005917 acylation reaction Methods 0.000 description 1
• 229940040563 agaric acid Drugs 0.000 description 1
• IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
• IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
• 235000010443 alginic acid Nutrition 0.000 description 1
• 239000000783 alginic acid Substances 0.000 description 1
• 229920000615 alginic acid Polymers 0.000 description 1
• 229960001126 alginic acid Drugs 0.000 description 1
• 150000004781 alginic acids Chemical class 0.000 description 1
• 239000003513 alkali Substances 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
• 229910021529 ammonia Inorganic materials 0.000 description 1
• VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
• 239000003708 ampul Substances 0.000 description 1
• 239000004037 angiogenesis inhibitor Substances 0.000 description 1
• 210000002159 anterior chamber Anatomy 0.000 description 1
• 230000001093 anti-cancer Effects 0.000 description 1
• 230000001028 anti-proliverative effect Effects 0.000 description 1
• 229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 description 1
• 239000000010 aprotic solvent Substances 0.000 description 1
• 239000011260 aqueous acid Substances 0.000 description 1
• 239000008346 aqueous phase Substances 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 229960005261 aspartic acid Drugs 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
• 235000010233 benzoic acid Nutrition 0.000 description 1
• 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
• 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
• 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
• CNXBZQYIWKKVCU-UHFFFAOYSA-N benzyl n-[3-[2-[4-amino-2-(4-phenoxyanilino)-1,3-thiazol-5-yl]-1,3-thiazol-4-yl]phenyl]carbamate Chemical compound S1C(C=2SC=C(N=2)C=2C=C(NC(=O)OCC=3C=CC=CC=3)C=CC=2)=C(N)N=C1NC(C=C1)=CC=C1OC1=CC=CC=C1 CNXBZQYIWKKVCU-UHFFFAOYSA-N 0.000 description 1
• YWBUHTQWQACROE-UHFFFAOYSA-N benzyl n-[3-[2-[4-amino-2-(4-sulfamoylanilino)-1,3-thiazol-5-yl]-1,3-thiazol-4-yl]phenyl]carbamate Chemical compound S1C(C=2SC=C(N=2)C=2C=C(NC(=O)OCC=3C=CC=CC=3)C=CC=2)=C(N)N=C1NC1=CC=C(S(N)(=O)=O)C=C1 YWBUHTQWQACROE-UHFFFAOYSA-N 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 125000002619 bicyclic group Chemical group 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-M bisulphate group Chemical group S([O-])(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
• 210000004204 blood vessel Anatomy 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
• 150000001649 bromium compounds Chemical class 0.000 description 1
• KDPAWGWELVVRCH-UHFFFAOYSA-N bromoacetic acid Chemical compound OC(=O)CBr KDPAWGWELVVRCH-UHFFFAOYSA-N 0.000 description 1
• KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229960005069 calcium Drugs 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 235000010216 calcium carbonate Nutrition 0.000 description 1
• 229960003563 calcium carbonate Drugs 0.000 description 1
• 229910000019 calcium carbonate Inorganic materials 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 230000036952 cancer formation Effects 0.000 description 1
• 239000004202 carbamide Substances 0.000 description 1
• 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
• 239000001569 carbon dioxide Substances 0.000 description 1
• 229960004424 carbon dioxide Drugs 0.000 description 1
• 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
• KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
• 231100000504 carcinogenesis Toxicity 0.000 description 1
• 230000009087 cell motility Effects 0.000 description 1
• 230000000973 chemotherapeutic effect Effects 0.000 description 1
• 150000001805 chlorine compounds Chemical class 0.000 description 1
• 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
• 210000003161 choroid Anatomy 0.000 description 1
• 238000011097 chromatography purification Methods 0.000 description 1
• 150000004777 chromones Chemical class 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 235000013985 cinnamic acid Nutrition 0.000 description 1
• 229930016911 cinnamic acid Natural products 0.000 description 1
• WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
• 150000001860 citric acid derivatives Chemical class 0.000 description 1
• 229940110456 cocoa butter Drugs 0.000 description 1
• 235000019868 cocoa butter Nutrition 0.000 description 1
• 239000012230 colorless oil Substances 0.000 description 1
• 238000004440 column chromatography Methods 0.000 description 1
• 229940126214 compound 3 Drugs 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 229910052802 copper Inorganic materials 0.000 description 1
• 239000010949 copper Substances 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 239000013058 crude material Substances 0.000 description 1
• 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
• 229940043378 cyclin-dependent kinase inhibitor Drugs 0.000 description 1
• 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• MJKYGUXBFYGLLM-UHFFFAOYSA-N cyclohexanamine;2-phosphonooxyprop-2-enoic acid Chemical compound NC1CCCCC1.NC1CCCCC1.NC1CCCCC1.OC(=O)C(=C)OP(O)(O)=O MJKYGUXBFYGLLM-UHFFFAOYSA-N 0.000 description 1
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
• 125000005534 decanoate group Chemical group 0.000 description 1
• 239000008367 deionised water Substances 0.000 description 1
• 229910021641 deionized water Inorganic materials 0.000 description 1
• 230000002074 deregulated effect Effects 0.000 description 1
• 230000003831 deregulation Effects 0.000 description 1
• 239000002274 desiccant Substances 0.000 description 1
• 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 description 1
• 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
• IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
• 235000011180 diphosphates Nutrition 0.000 description 1
• 208000035475 disorder Diseases 0.000 description 1
• 239000002270 dispersing agent Substances 0.000 description 1
• VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
• 238000007876 drug discovery Methods 0.000 description 1
• 229920001971 elastomer Polymers 0.000 description 1
• 238000002451 electron ionisation mass spectrometry Methods 0.000 description 1
• 230000001804 emulsifying effect Effects 0.000 description 1
• 210000004696 endometrium Anatomy 0.000 description 1
• 238000001952 enzyme assay Methods 0.000 description 1
• 201000005619 esophageal carcinoma Diseases 0.000 description 1
• CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
• WCQOBLXWLRDEQA-UHFFFAOYSA-N ethanimidamide;hydrochloride Chemical compound Cl.CC(N)=N WCQOBLXWLRDEQA-UHFFFAOYSA-N 0.000 description 1
• XBRSQWSJOUGKGU-UHFFFAOYSA-N ethyl 2-[4-amino-2-(4-sulfamoylanilino)-1,3-thiazol-5-yl]-1,3-thiazole-4-carboxylate Chemical compound CCOC(=O)C1=CSC(C2=C(N=C(NC=3C=CC(=CC=3)S(N)(=O)=O)S2)N)=N1 XBRSQWSJOUGKGU-UHFFFAOYSA-N 0.000 description 1
• MIABRZIVMBUXIF-UHFFFAOYSA-N ethyl 2-[4-amino-2-(4-sulfamoylanilino)-1,3-thiazol-5-yl]-5-benzyl-1,3-thiazole-4-carboxylate Chemical compound CCOC(=O)C=1N=C(C2=C(N=C(NC=3C=CC(=CC=3)S(N)(=O)=O)S2)N)SC=1CC1=CC=CC=C1 MIABRZIVMBUXIF-UHFFFAOYSA-N 0.000 description 1
• 235000019325 ethyl cellulose Nutrition 0.000 description 1
• 229920001249 ethyl cellulose Polymers 0.000 description 1
• 125000004494 ethyl ester group Chemical group 0.000 description 1
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
• LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
• 229940093471 ethyl oleate Drugs 0.000 description 1
• 238000002474 experimental method Methods 0.000 description 1
• 201000000497 familial melanoma Diseases 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 239000010685 fatty oil Substances 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 239000012467 final product Substances 0.000 description 1
• 238000002875 fluorescence polarization Methods 0.000 description 1
• 239000011737 fluorine Chemical group 0.000 description 1
• 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
• 230000037406 food intake Effects 0.000 description 1
• 150000004675 formic acid derivatives Chemical class 0.000 description 1
• VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
• 239000001530 fumaric acid Substances 0.000 description 1
• 125000002541 furyl group Chemical group 0.000 description 1
• 108020001507 fusion proteins Proteins 0.000 description 1
• 102000037865 fusion proteins Human genes 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 229940097043 glucuronic acid Drugs 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 229940074045 glyceryl distearate Drugs 0.000 description 1
• 229940075507 glyceryl monostearate Drugs 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 238000000227 grinding Methods 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 229920000591 gum Polymers 0.000 description 1
• 125000001188 haloalkyl group Chemical group 0.000 description 1
• 201000011066 hemangioma Diseases 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical class CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
• 125000005842 heteroatom Chemical group 0.000 description 1
• VPFMEXRVUOPYRG-UHFFFAOYSA-N hex-5-ynoic acid Chemical compound OC(=O)CCCC#C VPFMEXRVUOPYRG-UHFFFAOYSA-N 0.000 description 1
• 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 102000057090 human PTK2 Human genes 0.000 description 1
• 235000011167 hydrochloric acid Nutrition 0.000 description 1
• 229960000443 hydrochloric acid Drugs 0.000 description 1
• 238000007327 hydrogenolysis reaction Methods 0.000 description 1
• 230000000222 hyperoxic effect Effects 0.000 description 1
• 230000007954 hypoxia Effects 0.000 description 1
• 239000005457 ice water Substances 0.000 description 1
• 125000002883 imidazolyl group Chemical group 0.000 description 1
• 238000002513 implantation Methods 0.000 description 1
• 238000000099 in vitro assay Methods 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 230000031146 intracellular signal transduction Effects 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• 150000004694 iodide salts Chemical class 0.000 description 1
• 239000011630 iodine Chemical group 0.000 description 1
• 125000002346 iodo group Chemical group I* 0.000 description 1
• 239000003456 ion exchange resin Substances 0.000 description 1
• 229920003303 ion-exchange polymer Polymers 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
• 229940047889 isobutyramide Drugs 0.000 description 1
• KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical class CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
• 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 150000002540 isothiocyanates Chemical class 0.000 description 1
• CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
• 230000002147 killing effect Effects 0.000 description 1
• 239000004922 lacquer Substances 0.000 description 1
• 150000003893 lactate salts Chemical class 0.000 description 1
• 239000010410 layer Substances 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 229940057995 liquid paraffin Drugs 0.000 description 1
• 239000006194 liquid suspension Substances 0.000 description 1
• 229910052744 lithium Inorganic materials 0.000 description 1
• YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• 201000005202 lung cancer Diseases 0.000 description 1
• 208000020816 lung neoplasm Diseases 0.000 description 1
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
• 239000011976 maleic acid Substances 0.000 description 1
• 150000002688 maleic acid derivatives Chemical class 0.000 description 1
• 230000036210 malignancy Effects 0.000 description 1
• 150000002690 malonic acid derivatives Chemical class 0.000 description 1
• 229960002510 mandelic acid Drugs 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 238000001819 mass spectrum Methods 0.000 description 1
• 230000035800 maturation Effects 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 125000005905 mesyloxy group Chemical group 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 125000005341 metaphosphate group Chemical group 0.000 description 1
• 230000001394 metastastic effect Effects 0.000 description 1
• 206010061289 metastatic neoplasm Diseases 0.000 description 1
• AFVFQIVMOAPDHO-UHFFFAOYSA-M methanesulfonate group Chemical group CS(=O)(=O)[O-] AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
• 229920000609 methyl cellulose Polymers 0.000 description 1
• 150000004702 methyl esters Chemical class 0.000 description 1
• HAMGRBXTJNITHG-UHFFFAOYSA-N methyl isocyanate Chemical compound CN=C=O HAMGRBXTJNITHG-UHFFFAOYSA-N 0.000 description 1
• WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
• 235000010981 methylcellulose Nutrition 0.000 description 1
• 239000001923 methylcellulose Substances 0.000 description 1
• 125000002950 monocyclic group Chemical group 0.000 description 1
• 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• HDSHZLZMDAJJQD-UHFFFAOYSA-N n-(3-acetylphenyl)-5-chlorothiophene-2-carboxamide Chemical compound CC(=O)C1=CC=CC(NC(=O)C=2SC(Cl)=CC=2)=C1 HDSHZLZMDAJJQD-UHFFFAOYSA-N 0.000 description 1
• JMJUHQGPXJPKRH-UHFFFAOYSA-N n-[3-(2-bromoacetyl)phenyl]-5-chlorothiophene-2-carboxamide Chemical compound S1C(Cl)=CC=C1C(=O)NC1=CC=CC(C(=O)CBr)=C1 JMJUHQGPXJPKRH-UHFFFAOYSA-N 0.000 description 1
• YTSCJNGLTOKOEQ-UHFFFAOYSA-N n-[3-(2-bromoacetyl)phenyl]benzamide Chemical compound BrCC(=O)C1=CC=CC(NC(=O)C=2C=CC=CC=2)=C1 YTSCJNGLTOKOEQ-UHFFFAOYSA-N 0.000 description 1
• FZFIYOAPPGZOJL-UHFFFAOYSA-N n-[3-[2-(2,4-diamino-1,3-thiazol-5-yl)-1,3-thiazol-4-yl]phenyl]benzamide Chemical compound S1C(N)=NC(N)=C1C1=NC(C=2C=C(NC(=O)C=3C=CC=CC=3)C=CC=2)=CS1 FZFIYOAPPGZOJL-UHFFFAOYSA-N 0.000 description 1
• MKZVBTMMFZRBIW-UHFFFAOYSA-N n-[3-[2-(2,4-diamino-1,3-thiazol-5-yl)-5-methyl-1,3-thiazol-4-yl]phenyl]-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NC=2C=C(C=CC=2)C2=C(SC(=N2)C2=C(N=C(N)S2)N)C)=C1 MKZVBTMMFZRBIW-UHFFFAOYSA-N 0.000 description 1
• WEEWLOHTXTWMBE-UHFFFAOYSA-N n-[3-[2-[4-amino-2-(3,4,5-trimethoxyanilino)-1,3-thiazol-5-yl]-1,3-thiazol-4-yl]phenyl]-1-benzofuran-2-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(NC=2SC(=C(N)N=2)C=2SC=C(N=2)C=2C=C(NC(=O)C=3OC4=CC=CC=C4C=3)C=CC=2)=C1 WEEWLOHTXTWMBE-UHFFFAOYSA-N 0.000 description 1
• NJUDTSMZHYQJPR-UHFFFAOYSA-N n-[3-[2-[4-amino-2-(3,4,5-trimethoxyanilino)-1,3-thiazol-5-yl]-1,3-thiazol-4-yl]phenyl]-3-chlorobenzamide Chemical compound COC1=C(OC)C(OC)=CC(NC=2SC(=C(N)N=2)C=2SC=C(N=2)C=2C=C(NC(=O)C=3C=C(Cl)C=CC=3)C=CC=2)=C1 NJUDTSMZHYQJPR-UHFFFAOYSA-N 0.000 description 1
• XYGBBKUGEILYIM-UHFFFAOYSA-N n-[3-[2-[4-amino-2-(3,4,5-trimethoxyanilino)-1,3-thiazol-5-yl]-1,3-thiazol-4-yl]phenyl]-3-ethylbenzamide Chemical compound CCC1=CC=CC(C(=O)NC=2C=C(C=CC=2)C=2N=C(SC=2)C2=C(N=C(NC=3C=C(OC)C(OC)=C(OC)C=3)S2)N)=C1 XYGBBKUGEILYIM-UHFFFAOYSA-N 0.000 description 1
• BDKRQDHDPJXTSS-UHFFFAOYSA-N n-[3-[2-[4-amino-2-(3,4,5-trimethoxyanilino)-1,3-thiazol-5-yl]-1,3-thiazol-4-yl]phenyl]-3-methoxy-4-methylbenzamide Chemical compound C1=C(C)C(OC)=CC(C(=O)NC=2C=C(C=CC=2)C=2N=C(SC=2)C2=C(N=C(NC=3C=C(OC)C(OC)=C(OC)C=3)S2)N)=C1 BDKRQDHDPJXTSS-UHFFFAOYSA-N 0.000 description 1
• JTBSVSRISVJRMP-UHFFFAOYSA-N n-[3-[2-[4-amino-2-(3,4,5-trimethoxyanilino)-1,3-thiazol-5-yl]-1,3-thiazol-4-yl]phenyl]-4-chloropyridine-2-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(NC=2SC(=C(N)N=2)C=2SC=C(N=2)C=2C=C(NC(=O)C=3N=CC=C(Cl)C=3)C=CC=2)=C1 JTBSVSRISVJRMP-UHFFFAOYSA-N 0.000 description 1
• FUGSKXRVNNOHKU-UHFFFAOYSA-N n-[3-[2-[4-amino-2-(3,4,5-trimethoxyanilino)-1,3-thiazol-5-yl]-1,3-thiazol-4-yl]phenyl]-5-bromofuran-2-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(NC=2SC(=C(N)N=2)C=2SC=C(N=2)C=2C=C(NC(=O)C=3OC(Br)=CC=3)C=CC=2)=C1 FUGSKXRVNNOHKU-UHFFFAOYSA-N 0.000 description 1
• BYKRYNRDSVJNOD-UHFFFAOYSA-N n-[3-[2-[4-amino-2-(4-piperidin-1-ylsulfonylanilino)-1,3-thiazol-5-yl]-1,3-thiazol-4-yl]phenyl]benzamide Chemical compound S1C(C=2SC=C(N=2)C=2C=C(NC(=O)C=3C=CC=CC=3)C=CC=2)=C(N)N=C1NC(C=C1)=CC=C1S(=O)(=O)N1CCCCC1 BYKRYNRDSVJNOD-UHFFFAOYSA-N 0.000 description 1
• DPLQXOPNVYIHOL-UHFFFAOYSA-N n-[3-[2-[4-amino-2-(pyridin-3-ylamino)-1,3-thiazol-5-yl]-1,3-thiazol-4-yl]phenyl]benzamide Chemical compound S1C(C=2SC=C(N=2)C=2C=C(NC(=O)C=3C=CC=CC=3)C=CC=2)=C(N)N=C1NC1=CC=CN=C1 DPLQXOPNVYIHOL-UHFFFAOYSA-N 0.000 description 1
• IABQUQFYGOHZOQ-UHFFFAOYSA-N n-[3-[5-[4-amino-2-(3-morpholin-4-ylpropylcarbamoylamino)-1,3-thiazol-5-yl]-1,2,4-oxadiazol-3-yl]phenyl]-3-methylbenzamide Chemical compound CC1=CC=CC(C(=O)NC=2C=C(C=CC=2)C=2N=C(ON=2)C2=C(N=C(NC(=O)NCCCN3CCOCC3)S2)N)=C1 IABQUQFYGOHZOQ-UHFFFAOYSA-N 0.000 description 1
• IGSZJONBMJNESL-UHFFFAOYSA-N n-[3-[5-[4-amino-2-(phenylcarbamoylamino)-1,3-thiazol-5-yl]-1,2,4-oxadiazol-3-yl]phenyl]-3-methylbenzamide Chemical compound CC1=CC=CC(C(=O)NC=2C=C(C=CC=2)C=2N=C(ON=2)C2=C(N=C(NC(=O)NC=3C=CC=CC=3)S2)N)=C1 IGSZJONBMJNESL-UHFFFAOYSA-N 0.000 description 1
• NBUKMHXINQOFDI-UHFFFAOYSA-N n-[4-(chloromethyl)-1,3-thiazol-2-yl]acetamide Chemical compound CC(=O)NC1=NC(CCl)=CS1 NBUKMHXINQOFDI-UHFFFAOYSA-N 0.000 description 1
• XLEJYYWQUYAVNO-UHFFFAOYSA-N n-[4-amino-5-(4-benzoyl-1,3-thiazol-2-yl)-1,3-thiazol-2-yl]acetamide Chemical compound S1C(NC(=O)C)=NC(N)=C1C1=NC(C(=O)C=2C=CC=CC=2)=CS1 XLEJYYWQUYAVNO-UHFFFAOYSA-N 0.000 description 1
• ZUZCJTZHCRRLBC-UHFFFAOYSA-N n-[5-[2-[4-amino-2-(2-morpholin-4-ylethylcarbamoylamino)-1,3-thiazol-5-yl]-1,3-thiazol-4-yl]-2,4-difluorophenyl]-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NC=2C(=CC(F)=C(C=3N=C(SC=3)C3=C(N=C(NC(=O)NCCN4CCOCC4)S3)N)C=2)F)=C1 ZUZCJTZHCRRLBC-UHFFFAOYSA-N 0.000 description 1
• LPQCQLYQPOZBMW-UHFFFAOYSA-N n-[5-[2-[4-amino-2-(pyridin-4-ylmethylcarbamoylamino)-1,3-thiazol-5-yl]-1,3-thiazol-4-yl]-2,4-difluorophenyl]-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NC=2C(=CC(F)=C(C=3N=C(SC=3)C3=C(N=C(NC(=O)NCC=4C=CN=CC=4)S3)N)C=2)F)=C1 LPQCQLYQPOZBMW-UHFFFAOYSA-N 0.000 description 1
• MKIDEHRKLAONRP-UHFFFAOYSA-N n-[5-[5-(2,4-diamino-1,3-thiazol-5-yl)-1,2,4-oxadiazol-3-yl]-2,4-difluorophenyl]-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NC=2C(=CC(F)=C(C=3N=C(ON=3)C3=C(N=C(N)S3)N)C=2)F)=C1 MKIDEHRKLAONRP-UHFFFAOYSA-N 0.000 description 1
• FWVXNVVNMDZAMY-UHFFFAOYSA-N n-[5-[5-[4-amino-2-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1,3-thiazol-5-yl]-1,2,4-oxadiazol-3-yl]-2-chloro-4-methylphenyl]-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NC=2C(=CC(C)=C(C=3N=C(ON=3)C3=C(N=C(S3)C=3C=NC(=CC=3)N3CCN(C)CC3)N)C=2)Cl)=C1 FWVXNVVNMDZAMY-UHFFFAOYSA-N 0.000 description 1
• 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical class C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
• KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical class C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
• 125000001624 naphthyl group Chemical group 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 229910017604 nitric acid Inorganic materials 0.000 description 1
• IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
• 102000037979 non-receptor tyrosine kinases Human genes 0.000 description 1
• 108091008046 non-receptor tyrosine kinases Proteins 0.000 description 1
• 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
• 150000007523 nucleic acids Chemical class 0.000 description 1
• 102000039446 nucleic acids Human genes 0.000 description 1
• 108020004707 nucleic acids Proteins 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
• WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical class CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 239000004006 olive oil Substances 0.000 description 1
• 235000008390 olive oil Nutrition 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 229920000620 organic polymer Polymers 0.000 description 1
• 239000003791 organic solvent mixture Substances 0.000 description 1
• 229940092253 ovalbumin Drugs 0.000 description 1
• 230000002018 overexpression Effects 0.000 description 1
• 150000003891 oxalate salts Chemical class 0.000 description 1
• 235000006408 oxalic acid Nutrition 0.000 description 1
• 125000003145 oxazol-4-yl group Chemical group O1C=NC(=C1)* 0.000 description 1
• GNWXVOQHLPBSSR-UHFFFAOYSA-N oxolane;toluene Chemical compound C1CCOC1.CC1=CC=CC=C1 GNWXVOQHLPBSSR-UHFFFAOYSA-N 0.000 description 1
• 229910052763 palladium Inorganic materials 0.000 description 1
• FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
• 239000000312 peanut oil Substances 0.000 description 1
• 235000010987 pectin Nutrition 0.000 description 1
• 239000001814 pectin Substances 0.000 description 1
• 229920001277 pectin Polymers 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 108040007629 peroxidase activity proteins Proteins 0.000 description 1
• LIGACIXOYTUXAW-UHFFFAOYSA-N phenacyl bromide Chemical compound BrCC(=O)C1=CC=CC=C1 LIGACIXOYTUXAW-UHFFFAOYSA-N 0.000 description 1
• DYUMLJSJISTVPV-UHFFFAOYSA-N phenyl propanoate Chemical class CCC(=O)OC1=CC=CC=C1 DYUMLJSJISTVPV-UHFFFAOYSA-N 0.000 description 1
• WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical class OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 239000008363 phosphate buffer Substances 0.000 description 1
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
• DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 description 1
• 125000005498 phthalate group Chemical class 0.000 description 1
• 230000004962 physiological condition Effects 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 239000002504 physiological saline solution Substances 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 239000004014 plasticizer Substances 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 150000004804 polysaccharides Chemical class 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
• 229920001592 potato starch Polymers 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 230000002335 preservative effect Effects 0.000 description 1
• QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
• 229940080818 propionamide Drugs 0.000 description 1
• 229960004063 propylene glycol Drugs 0.000 description 1
• UORVCLMRJXCDCP-UHFFFAOYSA-N propynoic acid Chemical class OC(=O)C#C UORVCLMRJXCDCP-UHFFFAOYSA-N 0.000 description 1
• 230000029983 protein stabilization Effects 0.000 description 1
• 230000017854 proteolysis Effects 0.000 description 1
• 125000003373 pyrazinyl group Chemical group 0.000 description 1
• 125000003226 pyrazolyl group Chemical group 0.000 description 1
• 125000002098 pyridazinyl group Chemical group 0.000 description 1
• 125000000168 pyrrolyl group Chemical group 0.000 description 1
• QZZYYBQGTSGDPP-UHFFFAOYSA-N quinoline-3-carbonitrile Chemical class C1=CC=CC2=CC(C#N)=CN=C21 QZZYYBQGTSGDPP-UHFFFAOYSA-N 0.000 description 1
• DJXNJVFEFSWHLY-UHFFFAOYSA-N quinoline-3-carboxylic acid Chemical compound C1=CC=CC2=CC(C(=O)O)=CN=C21 DJXNJVFEFSWHLY-UHFFFAOYSA-N 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• 238000001959 radiotherapy Methods 0.000 description 1
• 238000011552 rat model Methods 0.000 description 1
• 239000000376 reactant Substances 0.000 description 1
• 230000022983 regulation of cell cycle Effects 0.000 description 1
• 230000008844 regulatory mechanism Effects 0.000 description 1
• 229920005989 resin Polymers 0.000 description 1
• 239000011347 resin Substances 0.000 description 1
• 230000000284 resting effect Effects 0.000 description 1
• 230000004233 retinal vasculature Effects 0.000 description 1
• 210000001210 retinal vessel Anatomy 0.000 description 1
• 229940100486 rice starch Drugs 0.000 description 1
• 229960004889 salicylic acid Drugs 0.000 description 1
• 239000012047 saturated solution Substances 0.000 description 1
• CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical class OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 1
• 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 239000002002 slurry Substances 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 235000010413 sodium alginate Nutrition 0.000 description 1
• 239000000661 sodium alginate Substances 0.000 description 1
• 229940005550 sodium alginate Drugs 0.000 description 1
• QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
• 239000011775 sodium fluoride Substances 0.000 description 1
• 235000013024 sodium fluoride Nutrition 0.000 description 1
• CMZUMMUJMWNLFH-UHFFFAOYSA-N sodium metavanadate Chemical compound [Na+].[O-][V](=O)=O CMZUMMUJMWNLFH-UHFFFAOYSA-N 0.000 description 1
• 239000012439 solid excipient Substances 0.000 description 1
• 238000003797 solvolysis reaction Methods 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 238000010186 staining Methods 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 239000008117 stearic acid Substances 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 239000011550 stock solution Substances 0.000 description 1
• 239000012089 stop solution Substances 0.000 description 1
• 125000005504 styryl group Chemical group 0.000 description 1
• TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical class OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 description 1
• 150000003890 succinate salts Chemical class 0.000 description 1
• 239000001384 succinic acid Substances 0.000 description 1
• LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
• 125000000565 sulfonamide group Chemical group 0.000 description 1
• BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
• 150000003871 sulfonates Chemical class 0.000 description 1
• 239000011593 sulfur Chemical group 0.000 description 1
• 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 239000002511 suppository base Substances 0.000 description 1
• 150000003892 tartrate salts Chemical class 0.000 description 1
• 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 150000003512 tertiary amines Chemical class 0.000 description 1
• 238000012956 testing procedure Methods 0.000 description 1
• DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 1
• CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
• 229940124597 therapeutic agent Drugs 0.000 description 1
• 125000005306 thianaphthenyl group Chemical group 0.000 description 1
• 125000004496 thiazol-5-yl group Chemical group S1C=NC=C1* 0.000 description 1
• 125000001544 thienyl group Chemical group 0.000 description 1
• 125000003396 thiol group Chemical group [H]S* 0.000 description 1
• QERYCTSHXKAMIS-UHFFFAOYSA-N thiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC=CS1 QERYCTSHXKAMIS-UHFFFAOYSA-N 0.000 description 1
• 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 230000036964 tight binding Effects 0.000 description 1
• 230000036962 time dependent Effects 0.000 description 1
• 239000004408 titanium dioxide Substances 0.000 description 1
• 230000026683 transduction Effects 0.000 description 1
• 238000010361 transduction Methods 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
• 229940029284 trichlorofluoromethane Drugs 0.000 description 1
• 125000001680 trimethoxyphenyl group Chemical group 0.000 description 1
• RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Substances C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 1
• 210000004881 tumor cell Anatomy 0.000 description 1
• 229910052721 tungsten Inorganic materials 0.000 description 1
• 210000003606 umbilical vein Anatomy 0.000 description 1
• JABYJIQOLGWMQW-UHFFFAOYSA-N undec-4-ene Chemical compound CCCCCCC=CCCC JABYJIQOLGWMQW-UHFFFAOYSA-N 0.000 description 1
• 229910052720 vanadium Inorganic materials 0.000 description 1
• 230000008728 vascular permeability Effects 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 229920002554 vinyl polymer Polymers 0.000 description 1
• 238000012800 visualization Methods 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• 239000001993 wax Substances 0.000 description 1
• 229940100445 wheat starch Drugs 0.000 description 1
• 230000029663 wound healing Effects 0.000 description 1
• GDJZZWYLFXAGFH-UHFFFAOYSA-M xylenesulfonate group Chemical group C1(C(C=CC=C1)C)(C)S(=O)(=O)[O-] GDJZZWYLFXAGFH-UHFFFAOYSA-M 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1
• 239000011592 zinc chloride Substances 0.000 description 1
• 235000005074 zinc chloride Nutrition 0.000 description 1
• JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 1
• 229910000166 zirconium phosphate Inorganic materials 0.000 description 1